USPTO serial 88064101
LUMEBLUE
Reviewed by CopyMark Law Group
Reg. 5952824Status 710
- Filing date
- Status date
- Registration date
- Jan 7, 2020
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LUMEBLUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dublin 2, IE
Dublin 2, IE
Dublin 2, IE
Dublin 2, IE
Dublin 2, IE
Dublin 2, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Pickerill
John Pickerill FREDRIKSON & BYRON, P.A.200 South Six StreetSuite 4000Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic agents, preparations and substances for medical and surgical purposes; Diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing colonoscopy; Diagnostic agents, preparations and substances for medical purposes, namely, the visualization of colonic polyps, adenomas, carcinomas, early stage cancers and other lesions in patients undergoing screening colonoscopy including patients at high risk of colorectal carcinoma (CRC), those with previous history of polyps, adenomas, carcinomas, early stage cancers and other lesions, patients with colorectal cancer and patients with relevant family history; Diagnostic reagents and coloring agent for medical and surgical use; Coloring agent for use with imaging medical equipment; Coloring agent for use with colonoscopic equipment; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the differentiation of the tissues of the intestines and colon and polyps, adenomas, carcinomas, early stage cancers and other lesions thereon; pharmaceutical preparations for use in endoscopic or colonoscopic diagnostic evaluation; pharmaceutical preparations for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions during gastrointestinal endoscopic procedures; pharmaceutical preparations for use in gastroenterology for colon and digestive system health and regulation; pharmaceutical preparations for use in endoscopy of the gastrointestinal tract; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal field; pharmaceutical preparations and preparations aiding detection, diagnosis, prevention and treatment related to the gastrointestinal endoscopy field; pharmaceutical preparations to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; pharmaceutical preparations, namely, coloring agent for use in endoscopic procedures; pharmaceutical compositions, namely, coloring agent for use in endoscopy; pharmaceutical preparations for use as reagents for medical use; pharmaceutical preparations, namely, coloring agent for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue for enhancing visualization during endoscopic procedures; pharmaceutical preparations containing dyes for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue coloring agent for pharmaceutical, medical and surgical purposes; pharmaceutical preparations containing coloring agent dye for pharmaceutical, medical and surgical purposes; methylene blue for pharmaceutical, medical, surgical and medical diagnostic purposes; dye for pharmaceutical, medical, surgical and medical diagnostic purposes | SECTION 8 - CANCELLED | — |
| 010 | Medical devices for use in endoscopic procedures of the gastrointestinal tract; Medical devices to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; Medical instruments to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; Medical devices for enhancing visualization during endoscopic procedures; Medical devices for enhancing visualization during endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; Medical devices for introducing compositions containing methylene blue into the human body for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices for introducing compositions containing dye into the human body for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices made with methylene blue for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices made with dye for enhancing visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions for pharmaceutical, medical, surgical and medical diagnostic purposes; Medical devices for use in endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; Medical devices for use in endoscopy of the gastrointestinal tract | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cosmo Technologies Ltd
- Other trademarks owned by Cosmo Technologies Ltd
- Other trademarks owned by Cosmo Technologies Ltd
- Other trademarks owned by Cosmo Technologies Ltd
- Other trademarks owned by Cosmo Technologies Ltd
- Other trademarks owned by Cosmo Technologies Ltd
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named LUMEBLUE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 17, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 7, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 22, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 17, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 4, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 7, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 7, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 7, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 5, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 28, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 7, 2018 | NWAP | NEW APPLICATION ENTERED | — |